CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
about
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
CheckMate-032 Study: Efficacy ...... astatic Esophagogastric Cancer
@en
CheckMate-032 Study: Efficacy ...... astatic Esophagogastric Cancer
@nl
type
label
CheckMate-032 Study: Efficacy ...... astatic Esophagogastric Cancer
@en
CheckMate-032 Study: Efficacy ...... astatic Esophagogastric Cancer
@nl
prefLabel
CheckMate-032 Study: Efficacy ...... astatic Esophagogastric Cancer
@en
CheckMate-032 Study: Efficacy ...... astatic Esophagogastric Cancer
@nl
P2093
P2860
P356
P1476
CheckMate-032 Study: Efficacy ...... astatic Esophagogastric Cancer
@en
P2093
Cecile Dorange
Christopher T Harbison
Dirk Jaeger
Emiliano Calvo
Filippo de Braud
Jeffry Evans
Johanna Bendell
Joseph W Kim
P2860
P304
P356
10.1200/JCO.2017.76.6212
P407
P577
2018-10-01T00:00:00Z